PKM and metabolic dysfunction-associated steatohepatitis: The pattern of PKM2 expression in inflammatory liver diseases may lead to the development of novel biomarkers for accurate diagnosis, either independently or along with liver biopsy, which is the gold standard for NASH diagnosis [44,45].